BlackRock Institutional Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$48.1M	Buy	442,854 +5,517	+1%	+$657K	0.01%	1376
2016 Q3	$72M	Buy	437,337 +21,523	+5%	+$3.39M	0.01%	1070
2016 Q2	$59.3M	Buy	415,814 +3,813	+0.9%	+$556K	0.01%	1134
2016 Q1	$52.9M	Sell	412,001 -3,375	-0.8%	-$399K	0.01%	1185
2015 Q4	$62M	Buy	415,376 +8,379	+2%	+$1.42M	0.01%	1121
2015 Q3	$67.5M	Buy	406,997 +60,949	+18%	+$13.4M	0.01%	1056
2015 Q2	$83.5M	Buy	346,048 +17,192	+5%	+$4.58M	0.01%	1001
2015 Q1	$92.7M	Buy	328,856 +9,915	+3%	+$2.15M	0.01%	972
2014 Q4	$49.8M	Buy	318,941 +11,047	+4%	+$2.04M	0.01%	1301
2014 Q3	$72.9M	Buy	307,894 +8,530	+3%	+$2.17M	0.01%	1028
2014 Q2	$70.8M	Buy	299,364 +64,633	+28%	+$17M	0.01%	1093
2014 Q1	$77.4M	Buy	234,731 +153,164	+188%	+$51.7M	0.01%	1024
2013 Q4	$5.57M	Sell	81,567 -2,161	-3%	-$125K	﹤0.01%	2726
2013 Q3	$5.78M	Buy	83,728 +13,349	+19%	+$659K	﹤0.01%	2657
2013 Q2	$3.16M	Buy	+70,379	New	+$2.4M	﹤0.01%	2891